Biggest News Aggregation in the World
📰 Sysmex Corp News

Page 5 - Sysmex Corp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sysmex Corp. Real-time updates on events, politics, business and more.

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial | Colorectal Cancer | JAMA

This randomized clinical trial assesses the effect of adding panitumumab vs bevacizumab to standard first-line chemotherapy on overall survival among patients w
United States Eteläuomen Läi Solasia Pharma Marko Rehn Takayuki Yoshino Merck Serono

Prosus (OTCMKTS:PROSY) and Sysmex (OTCMKTS:SSMXY) Head to Head Comparison

Sysmex (OTCMKTS:SSMXY – Get Rating) and Prosus (OTCMKTS:PROSY – Get Rating) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 0.0% of Prosus shares are owned by […]
United States Noord Holland Asia Pacific International Holdings Sysmex Corp Get Rating

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sysmex (OTCMKTS:SSMXY) Trading Up 1.1%

Shares of Sysmex Co. (OTCMKTS:SSMXY – Get Rating) were up 1.1% on Friday . The company traded as high as $32.73 and last traded at $32.73. Approximately 11,105 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 23,155 shares. The stock had previously closed at $32.37. Sysmex Stock […]
Sysmex Co Sysmex Corp Get Rating Sysmex Daily Otcmkts Ssmxy

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science